The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics.
Marco Onofrj, Mirella Russo, Stefano Delli Pizzi, Danilo de Gregorio, Antonio Inserra, Gabriella Gobbi, Stefano L. Sensi
Translational Psychiatry December 13, 2023 DOI: 10.1038/s41398-023-02691-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Brain's thalamus Vital sensory relay Region Filters sensory information Thalamic function Psychotic symptoms Brain misinterpreting reality How psychosis develops Brain function Malfunction Impairment Disruptions Neurological disorders Neurodegenerative diseases Effects of psychedelics Therapy development Promising new avenues Developing effective therapies Insights |
| Citations | 42 |
| Key points | Proposes that ThalamoCortical Dysrhythmia is a crucial driver of psychosis in Parkinson's disease and Dementia with Lewy Bodies, linking these symptoms to altered states of consciousness. |
Abstract
The PD-DLB psychosis complex found in Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB) includes hallucinations, Somatic Symptom/Functional Disorders, and delusions. These disorders exhibit similar presentation patterns and progression. Mechanisms at the root of these symptoms also share similarities with processes promoting altered states of consciousness found in Rapid Eye Movement sleep, psychiatric disorders, or the intake of psychedelic compounds. We propose that these mechanisms find a crucial driver and trigger in the dysregulated activity of high-order thalamic nuclei set in motion by ThalamoCortical Dysrhythmia (TCD). TCD generates the loss of finely tuned cortico-cortical modulations promoted by the thalamus and unleashes the aberrant activity of the Default Mode Network (DMN). TCD moves in parallel with altered thalamic filtering of external and internal information. The process produces an input overload to the cortex, thereby exacerbating DMN decoupling from task-positive networks. These phenomena alter the brain metastability, creating dreamlike, dissociative, or altered states of consciousness. In support of this hypothesis, mind-altering psychedelic drugs also modulate thalamic-cortical pathways. Understanding the pathophysiological background of these conditions provides a conceptual bridge between neurology and psychiatry, thereby helping to generate a promising and converging area of investigation and therapeutic efforts.
Citations in the library
Cited by 13
- Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review. Journal of Affective Disorders June 15, 2024
- Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study. Neuropsychopharmacology October 1, 2024
- Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review Journal of Psychopharmacology January 20, 2025
- The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State. Human Brain Mapping April 1, 2025
- The psychedelic-peptide paradox: a hormetic hypothesis. Comprehensive Psychoneuroendocrinology June 2, 2025
and 8 more in the library
Cites 55
- The Brain's Default Mode Network Annual Review of Neuroscience May 4, 2015
- Default Mode Network Activity and Connectivity in Psychopathology Annual Review of Clinical Psychology March 29, 2012
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
and 50 more in the library